Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Israel

Israel Articles

Companies

Israel's Teva Pharmaceutical Industries has moved to end speculation that it is eying up an acquisition of Germany's Stada Arzneimittel. Teva's North American CEO William Marth stated... 2008-09-22


Industry

Israel's Teva Pharmaceutical Industries has announced that it has received EU marketing authorisation for TevaGrastim (filgrastim), a biosimilar of Amgen's Neupogen. Filgrastim is... 2008-09-18


Companies

Israel is close to joining the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme (PIC/S), following a successful check of pharmaceutical manufacturing... 2008-08-13


More ARTICLES

Companies

According to Globes [online], a survey by the Manufacturers Association of Israel reported that pharmaceutical exports grew by 44% in Q208 from Q1. The survey also showed that the... 2008-07-24


Companies

Not to be outdone by its research-focused rivals, Israel's Teva Pharmaceutical Industries has once again demonstrated its desire to expand by acquisition, launching a US$7.46bn bid... 2008-07-21


Companies

Following the rejection of its merger agreement with Israel-based drug manufacturer Taro Pharma , India's Sun Pharma has launched a hostile takeover bid.

2008-07-15

Companies

The US FDA has accepted for review Momenta Pharmaceuticals' generic version of Teva Pharmaceutical's Copaxone (glatiramer).

2008-07-15

Companies

US-based Mylan has signed an agreement with India's NATCO Pharma to market a generic version of Israeli drugmaker Teva's multiple sclerosis drug Copaxone (glatiramer) in the US, Europe,... 2008-06-12

Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries